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1. ABSTRACT
A number oftheoretical and practical limits ofhigh-speed flow cytometry/cell sorting are important for clinical
diagnostics and therapeutics. Three applications include: (1) stem cell isolation with tumor purging for minimal
residual disease (MRD) monitoring and treatment, (2) identification and isolation ofhuman fetal cells from maternal
blood for prenatal diagnostics (PD) and in-vitro therapeutics, and (3) high-speed library screening for recombinant
vaccine production (RVP) against unknown pathogens.
For clinical diagnostics it is important to obtain highly purified cell subpopulations for subsequent DNA
sequencing or gene expression microarray analyses. Using single-cell DNA PCR and TA cloning techniques it is
possible to detect a single base pair mutation in a single gene of a tumor cell for MRD or PD. Practical gene
expression microarray analysis requires analyses ofrelatively large numbers ofpurified cell subpopulations isolated
from heterogeneous populations unless sequences can be reliably pre-amplified. Post-separation molecular
characterization technologies such as single-cell PCR and single cell sequencing and gene expression microarray
analyses depend on the delivery of purified cells or cell subpopulations. Otherwise these molecular characterization
technologies superimpose the DNA sequence or gene expression profile patterns ofthe different cell types present.
In particular, gene expression profiles from microarray analyses performed on mixtures of cell types, cell cycle and
cell differentiation stages, activated and non-activated cells are at best compromised in value and at worst of little
value.
Clinical therapeutics requires safe and sterile isolation of cell subpopulations for subsequent manipulation (e.g.
genetic-engineering) prior to re-infusion into the patient in MRD therapeutics. Contaminating cell types, especially
those dangerous to the patient (e.g. tumor cells within autologous transplants), can compromise patient therapy.
Some measure of quality assurance is needed to give a measure of the purity of the cell separation.
RVP against unknown pathogens requires very high-speed screening of large libraries of bacteria containing
expressed human immunoglobulin sequences. Theoretical and practical implications ofhigh-speed library screening
are discussed in this context.
Keywords: flow cytometry, cell sorting, high-throughput screening, gene expression microarrays, minimal residual
disease monitoring, fetal cell diagnostics, autologous transplantation, recombinant vaccines
2. INTRODUCTION
2.1 The Need for high-throughput cell separation technologies for clinical dia2nostics and therapeutics
High throughput cell separation technologies are growing increasingly important for clinical diagnostics and
therapeutics. The sensitivity of new molecular diagnostic techniques means that the molecular results of
contaminating cell types can at best compromise the sensitivity ofthe measurement. At its worst, the presence of
contaminating cell types can obscure or even reverse the diagnostic result.
The problem is especially important in clinical applications such as minimal residual disease monitoring. For
example, in metastatic breast cancer, the tumor cells may be present in only a few cells per million in the bone
marrow or peripheral blood ofthe patient. To adequately sample the patient's bone marrow or peripheral blood
requires statistical sampling of at least several hundred million cells. This would require many hours or even days by
conventional flow cytometry and at conventional cell sorting speeds.
The importance of tumor purging has recently been demonstrated by gene marking experiments (Brenner, 1993;
Brenner et al., 1995). These experiments show that failure to purge tumor cells from autologous transplants may
results in killing an immuno-compromised cancer patient with his or her own tumor cells.
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2.2 Detection and Isolation of human fetal cells from maternal blood fore fetal cell diagnostics
The detection and isolation of fetal cells from maternal blood for subsequent genetic analysis has been a dream
since the early 1970's. The reality has been considerably more sobering in terms ofthe difficulty and the lack of
good probes for fetal cells. Most fetal cells have been detected either on the basis ofthe presence ofpaternal HLA-
antigens or on the basis of differentiation antigens expressed on early nucleated erythrocytes not normally found in
large numbers in the adult blood. But the sobering reality has been that it is virtually impossible to make even a very
good monoclonal antibody against HLA antigens that does not have a high rate of false positives when trying to
label rare fetal cells of typical normal frequencies of 1 06 or less in a pregnant mother' s blood. Likewise, it is
difficult to use differentiation antigens on nucleated erythrocytes without a high-rate of false-positives due to the
increased generation of nucleated erythrocytes in the stressed bone marrow of pregnant women. Further
complicating the problem is the possible existence of circulating lymphocytes from earlier pregnancies that may
persist for many years. In this paper we describe new technologies and methods that may help make the overall goal
more reasonable.
The isolation of a true human fetal cell from maternal blood is difficult in the case of a grossly abnormal fetal cell
(e.g. a trisomy 13 , 18 or 21) or in the case where the genetic disease is not X-linked (e.g. in the female fetus). To
date most flow cytometry/cell sorting of fetal cells has looked only for trisomies and the presence of male fetal cells
bearing the Y-chromosome. With the near completion ofthe Human Genome Project and a subsequent analysis of
the range of "normal" polymorphisms, it should be possible to take advantage of DNA microarrays to screen for
hundreds or even thousands ofpossible human mutations leading to diseases not detectable at the gross abnormality
level.
2.3 High-throughput screening of libraries
High-throughput screening of libraries containing recombinant DNA, oligonucleotides, or amino acid sequences
has great promise for therapeutics. One example to be discussed in this paper is that ofproduction of recombinant
vaccines by high-throughput screening of large numbers of recombinant clones of human immunoglobulin
recognition sequences within a bacterial library. This therapeutics application requires very high-speed analysis and
cloning of bacterial clones containing the proper immunoglobulin recognition sequence against the antigen of
interest.
2.4 The importance of separating pure cells or cell subpopulations for subseQuent molecular analyses by
single-cell DNA PCR and for gene expression microarray analysis
When purified rare cells can be obtained from heterogeneous cell mixtures such as bone marrow (in the case of
MRD monitoring) or from maternal blood (for fetal cell diagnostics), specific gene mutations can be readily
diagnosed by single-cell PCR and single-cell DNA sequencing.
For example, we have previously shown that in the case of fetal cell diagnostics, we could successfully identify
and isolate non-grossly abnormal fetal cells on the basis of HLA type using monoclonal anti-HLA antibodies. But
even with an excellent quality monoclonal antibody of high-specificity, we were able to obtain separated cells of
only 10 percent purity. In these experiments we were able to isolate from the blood of a mother in her ninth week of
pregnancy a sample often cells that contained a single fetal cell on the basis ofPCR amplification ofthe DNA of
those ten cells with subsequent HLA typing using allele-specific oligonucleotides (ASO) as shown in Figure X in
the Results section. This led us to work on improved single-cell PCR amplification methods as well as introducing
the concept of multi-tube, single cell PCR that no longer requires that the molecular selection probe (in this case a
monoclonal antibody) be perfect in its selection of the rare cell of interest. The selection probe or probes need only
be good enough to enrich enough that the number of single cells sorted for subsequent single-cell PCR and
molecular diagnosis be small enough to be reasonable and cost-effective.
While further work on this fetal cell diagnostics application was halted prematurely through an interruption of
research funding and a laboratory move, we were able to pursue this concept in a different application, namely the
detection of metastatic breast cancer cell clones containing tumor suppressor gene mutations that allow these cells to
escape detection by the immune system. In feasibility experiments involving defines cell mixtures of human breast
cancer cell lines with well- defined tumor suppressor gene mutations and human bone marrow cells, we were able to
demonstrate detection of these cells at a frequency of 106 with a cell sorting purity of 30 percent using the single-
cell, multi-tube cell sorting concept. Furthermore, we were able to sort single tumor cells and demonstrate the
feasibility of single-cell DNA sequencing of a single base pair deletion in the PTEN tumor suppressor gene of these
cells.
Attempts to perform single cell RT-PCR met with limited success. While we could routinely perform such
analyses on 5 or more cells, single cell results, while possible, were not routinely reproducible. This led us to
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consider other alternatives such as gene expression microarrays. Microarrays are generally used for applications
involving a minimum of approximately one-halfmillion cells. However, pre-amplification methods are being
developed by other groups to allow microarray analyses of a few thousand cells. In preliminary work we were able
to perform a gene expression microarray analysis on 1000 cells, but all genes were not amplified equally as seen by
comparison with microarray analyses of conventional, unamplified cDNA from cells. Further work will involve
more linear amplification methods and more sensitive detection methods. However, we were able to demonstrate in
these experiments the importance of analyzing purified cell subpopulations rather than cell mixtures. As seen in
Figure Y of the Results section, the gene expression profiles of cell mixtures roughly follow the expected result of a
superposition ofthe gene expression profiles ofthe different cell types present according to their relative abundance.
3. METHODS
3.1 Methods for high-throughput flow cytometry/cell sorting
Over the past twenty years our laboratory has developed a large number of instrument hardware and software
technologies and methodologies for dealing with the high-throughput processing of cells and other objects (Cupp et
al. 1984; Leary et at., 1991; Leary et at., 1996b; 1997b) as well as a wide variety ofcell labeling and manipulation
techniques for "rare-event analysis", namely the analysis and sorting of cell subpopulations with frequencies less
than 0. 1 percent (for a reviews see Leary, 1994; Leary, 2000). More recently, we have extended these procedures to
the realm of "ultra-rare" cells, namely those cell subpopulations of frequencies less than 0.00 1 percent (Leary et at.,
1995; 1996; 1997; 1998a; 1998b; 1999a; 1999b; 2000a; 2000b; Hokanson et at., 1999). To accomplish this level
of high-throughput cell processing we have not only developed a very high-speed flow cytometers/cell sorter, but
also given it a sophisticated hardware/software, two-stage cell classification and sorting system capable of using
real-time multivariate statistical classifications, including measures of the probability of correct cell classification
(also referred to sometimes as "penalties of misclassification")(for patents see Leary et at., 1993;1998 and Corio
and Leary, 1993;1996). Going faster alone does not due the job if one generates huge numbers of false-positives.
Rare cell sampling statistics is also an important issue that we have studied at some length and for which we have
developed new rare-cell sampling statistical techniques (Rosenbtatt et at., 1997).
The result ofthese efforts has been the development ofa high-throughput cell sorter (Figure 1) that we are now
adapting to a number ofprojects including: (a) minimal residual disease monitoring, including single cell DNA
sequencing of rare sorted metastatic breast cancer cells (b) autologous stem cell transplantation with simultaneous
tumor purging, (c) high-throughput screening of recombinant libraries for recombinant vaccine production, and (d)
high-throughput screening of combinatorial chemistry libraries on microbeads.
High-Throughput Cell Processing for Clinical
Diagnostics and Therapeutics
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Figure 1 : Overview of a 6-color
high-speed flow cytometer with a
single-layer neural network
architecture that allows real-time
classification/sort decisions on the
basis of multivariâte statistical
functions.
For high recovery of cells
sorted at high speeds and for
efficient single-cell recovery, we
often sort cells of interest straight-
ahead, achieving sort recoveries of
more than 95 percent even at the
single-cell level at rare cell
frequencies as low as 10.6. The
multivariate statistical functions
calculated in real-time provide for
statistically-based sort boundaries
and a measure of the degree of
misclassification.
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Interestingly cell sorters are inherently much more efficient at higher cell processing speeds as long as the
instrument deadtime, the time period that it takes for an instrument to process one cell and be ready to measure the
next cell, can be kept very low. The deadtime first stage of our 2-stage cell processing system is less than 2
microseconds as compared with typical deadtimes of 1 0-1 5 microseconds on most commercial cell sorters and
approximately 5 microseconds on the fastest commercial cell sorter presently available. A detailed discussion of the
importance of instrument deadtime from the viewpoint of queuing theory is beyond the scope of this paper but has
been clearly and simply discussed in two book chapters (Leary, 1994; Leary, 2000). A very simple illustration that
makes the point obvious is show n in Figure 2.
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4. RESULTS
4.1 Development of instrumentation for high-throughput flow cytometry and cell sortin2
The development of high-speed cell sorters suitable for detection and isolation of rare cells involves a number of
factors including instrumentation, data analysis Software, and cell preparation methods (for a general review see
Leary, 1994). We have previously described our development of instrumentation for high-throughput flow
cytometry and cell sorting (Leary et at., 1995; 1996; 1997; 1998; 1999; Leary, Corio, and McLaughlin
1993;1998, Corio and Leary, 1993; 1996, for a recent review see Leary, 2000). Briefly in terms of the
instrumentation, we have developed a 2-stage, real-time, cell classification system for high-speed, high-resolution
cell sorting as shown in Figure 3:
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Figure 2: Cell sorters are much more
efficient at very high throughput speeds in
terms of the enrichment factor from the
original rare cell concentration to the final
sorted rare cell concentration. In this
concept figure a cell of original frequency
of 1 O (1 rare cell per 1 00,000 total cells)
can be sorted at 100,000 cells/sec with a
sorter capable ofgenerating 33,000
droplets/sec. A high-speed first-pass sort
enrichment ofmore than 30,000-fold,
based on up to 3 rare parameters and 5
additional total parameters, can be
attained. Sorted cells can then be re-sorted
to any desired purity, based on the quality
ofthe selection probes.
Figure 3: Schematic ofa real-
time, 2-stage, statistical
decision making system as
implemented in a high-speed
cell sorter in our laboratory.
The first stage processes
incoming signals with a
deadtime ofless than 2
microseconds, counting all cells
and classifying them into
"positives", "negatives" or
"not-sures". The "positives"
and "not-sures" are then sent to
a second-stage system that uses
more complex multivariate
statistical functions to better
classify these cells and to
provide a measure of the degree
of potential misclassification.
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Detection of mutations in breast cancer tumor suppressor genes by hi2h-throughput flow cytometry, sin2le
ji sorting, and single-cell sequencing
An example ofrare tumor cell detection we have previously described (Leary et at., 1999) is shown in a model
system in Figure 4. A rare tumor cell clone was mixed with a human T -cell line at a frequency of 1 O. A defined
cell mixture of CEM/C7 (human T-cells) and MCF-7 cells (ATCC Number: HTB-22, Name: MCF-7 (human breast
carcinoma cells)) was constructed to yield a frequency of 1 6tumor cells for flow cytometry and cell sorting. The
cells were then analyzed on the basis of cytokeratin positive fluorescence and for negative labeling with CD45 are
shown below:
We then tested for sort recovery and purity in the case ofa defined cell mixture ofMCF-7 and CEM-C7 cells. We
used DNA HLA-DQalpha typing ofthe MCF-7 cells [1
.2, 4 ] and the CEM/C7 cells [1 .2, 1 .3] to see our efficiency
of successful selection of tumor cells. The primers and oligo dot blot probes used in these studies are as described in
Leary et at., 1999b. Since the amount ofPCR- amplified DNA from a single cell is too small to be seen by
conventional ethidium bromide staining ofthe PCR products on a gel, enzymatic amplification techniques must be
used. One such technique we have used is ECL (Enhanced Chemiluminescence; Amersham Life Science, Catalog
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Figure 4: Flow cytometric results from a defined cell mixture of iO frequency MCF-7 cells in a major
population ofhuman CEM/C7 T-cells. Cells were labeled with a PE-conjugated anti-CD45 antibody and a FITC
conjugated anti-cytokeratin antibody. A small subpopulation ofrare MCF-7 cells was detected in region R2 in
an aliquot ofthe sample. Cells in this region were then sorted at the single cell level for subsequent PCR
analysis, TA cloning, and DNA sequencing. The four tumor cells have been highlighted as dark enlarged circles
()in the flow cytometric distribution for easier viewing.
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No. RPN 3021) whereby Southern blotting is performed with enzymatically labeled complementary sequence
oligonucleotide ("oligo") probes. An enzymatic reaction gives rise to chemiluminescence that can then be detected
on X-ray film, but without the hazards and disposal problems ofradioactive probes. ECL provides an enzymatic
amplification factor of approximately 1000 times, permitting detection ofPCR products from single cells (Leary et
at., 1999b).
4.3 Singte-cetl DNA seiuencin2 resutts from TA ctoning:
As we described previously (Leary et at., 1999b; Leary Ct at. 2000a) DNA sequencing of sorted single tumor
cells can be performed. We sorted single cells with several mutations, including the BT-549 cells which have a
single base pair mutation in the so- called PTEN gene, a tumor suppressor gene that has been previously described
(Li et at., 1997). A clone of BT-549 cells was analyzed by flow cytometry and sorted into single PCR tubes for
subsequent analysis by PCR and TA cloning. The DNA from the PTEN gene region of sorted single cells was
amplified by PCR and cloned into a TA cloning vector. The vector was then amplified by growth in host E. Coli
bacterial cells, and the plasmid DNA was isolated and purified. This purified plasmid DNA containing the PTEN
gene sequences from sorted single cells was then analyzed on a DNA sequencing instrument. A typical DNA
sequencing result from a single sorted BT-549 cells is shown in Figure 4B. Cells without the mutated sequence
show normal PTEN gene sequences (data not shown).
An alignment analysis of the above sequence data reveals a single base pair deletion at nucleotide 61 of exon 8 of
PTEN gene indicative of the PTEN mutation present in these BT-549 cells.
cett diagnostics
One approach to this challenging problem is to use very high-throughput flow cytometry to obtain adequate
sampling statistics (e.g. 50 rare cells or more) and sophisticated cell classification algorithms to reduce the number
of false-positives. By using single-cell, multi-tube cell sorting and PCR amplification techniques, perhaps with
single-cell DNA sequencing of particular genes of interest, neither the selection markers nor the sorting has to be
perfect. It only has to be good enough to be practical.
Shown in Figure 5 is a clear illustration ofthe utility of a high-throughput flow cytometric analysis followed by
a single-cell, multi-tube sort with subsequent single-cell PCR analysis. Once the rare fetal cells from a 9-week
pregnant mother were identified on the basis of erythroid-lineage monoclonal antibody markers and the presence of
a nucleus using 7-amino-actinomycin D, 10 putative fetal cells were isolated by high-resolution single-cell sorting
and analyzed at the DNA level using allele-specific oligonucleotides. Results in clearly show that in the 10-cell sort
at least one of the cells had to be fetal as based on subsequent HLA typing of the mother, father and of that fetus
after birth.
Several examples of rare cell analyses as performed in this author's laboratory illustrate different strategies for
flow cytometric analysis and/or sorting of rare cell subpopulations. These strategies were formulated for specific
situations and subject to subsequent characterizations of sorted rare cells by different techniques. As an example of
results that can be obtained with a high-speed cell sorter, cells were processed in our laboratory at 85,000 cells/sec
for 3-color immunofluorescence using two positive (but not fetal-cell unique) selection markers (CD34 and CD71)
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Figure 4B: DNA sequencing of the PTEN gene region from a single sorted cell. Alignment shows:
1 1516 3031 4546 6061 90
1 WTPTEN TCCTGGTATGAAGAA TGTATTTACCCAAAA GTGAAACATTTTGTC CTAAAAAAAAAAAAA GAA 63
2 BT-549 TCCTGGTATGAAGAA TGTATTTACC- AAAA GTGAAACATTTTGTC CTAAAAAAAAAAAAA GAA 62
4.4 High-throughput detection and isolation of human fetal cells from maternal blood for non-invasive fetal
Proc. SPIE Vol. 4255 21
Downloaded From: http://proceedings.spiedigitallibrary.org/ on 12/02/2015 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
and one negative selection marker (CD45). This application used for selection ofhuman fetal cells from the blood of
a pregnant woman involves flow cytometric analysis of early erythroid cells (highly enriched but not specific for
rare fetal cells) in unlysed maternal whole blood (processed at a concentration of approximately 5x108 cell/ml).
Data are shown in Figure 5 (9). Results dramatically illustrating the importance ofpositive and negative selection
marker strategies is shown in Figure 5. The labeling strategy is shown in Figure 5A. The negative selection gate is
shown in Figure 5B. As shown by comparing Figure 5Cwith its isotype control in Figure 2E it would be difficult
or impossible to sort out rare cells of interest due to the high non-specific background. However, when only one
negative selection marker, in this case CD45 coupled to a phycoerythrin-cyanine-5 (PE-Cy5) tandem-conjugate
energy transfer probe which labels mature maternal leukocytes as well as dead/damaged and non-specifically
binding cells, is used the situation changes dramatically. Comparison of Figure 5D and Figure 5F reveal an easily
identifiable subpopulation of "putative" fetal cells that can be sorted.
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The boxed region of interest in Figure 5E contains a calculated frequency of 1 .8 x 1 O' based on a total sample
size of 108 cells. Finite sampling theory gives the 95%confidence range ofthe rare cell frequency to be between 1.8
x iO-7 and 2.0 x i07. To have 95% probability of being able to sample (and sort in the absence of other possible
losses) 10 cells from a sample aliquot containing 108 cells would require us to process at least 71% of the sample.
Such calculations can obviously be used to determine how much sample can be first analyzed to set sorting gates
while still allowing for enough rare cells to remain for subsequent sorting. This application also shows why it is
difficult to use depletion cell separation technologies (e.g. affinity columns and magnetic bead sorting). While it is
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Figure 5: An example of3-color fluorescence with positive and negative selection markers and a high-speed
analysis of a rare cell subpopulation where original frequency is desired. Analysis was done on whole blood
without any fractionation procedures. A total of iO cells were analyzed for each distribution in approximately 20
minutes per sample at a rate of 85,000 cells/sec. By gating on the negative selection marker, a subpopulation of
fetal cells hidden by the overall distribution is revealed in the boxed region of Figure 5E.
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theoretically possible to allow sorting on the basis of levels of antigen expression with these technologies, these
sorting levels are much more difficult to control. In the sample shown in Figure 5, approximately half of the fetal
cells are CD45 dim rather than CD45 negative. It is also very difficult to recover cells from affinity columns or
through magnetic sorting devices when there may be only a few rare cells although such methods are useful as cell
isolation or pre-enrichment procedures to obtain larger numbers of not very rare cells (e.g. 1 % subpopulations)
when the total number of rare cells available is large (greater than a few thousand cells). Multiple sets of PCR
primers can be used on single cells to simultaneously confirm the identity of the cell and to check for specific gene
sequence abnormalities. Rare cell subpopulations should always be thought of as "putative" until the rare cells are
sorted and characterized, preferably by unequivocal molecular means such as PCR-amplified cell specific DNA
sequences. While tandem conjugate energy transfer probes are extremely useful for multicolor fluorescence flow
cytometric experiments, they can sometimes lead to problems when cells are dimly positive (in this case for PB) due
to energy transfer "leakage". An energy transfer probe that "leaks' fails to achieve energy transfer and gives off
donor rather than aèceptor fluorescence (in this case it would falsely give off PB rather than Cy5 fluorescence). In
that case it is difficult to distinguish between cells with leaky energy transfer probes and trues fluorescence positive
cells (in this case PB positive cells). However, even somewhat leaky energy transfer probes can still be used
successfully as negative selector probes since any cells which are positive for the donor fluorescence will also be
positive for acceptor fluorescence and all acceptor fluorescence positive cells are eliminated. This is analogous to
the situation of not worrying about propidium iodide (P1) fluorescence in dead/damaged cells spectrally overlapping
with fluorescein fluorescence since all PT-positive cells will be gated out of the distribution. This is why we have
used the tandem conjugate probe on the negative selector in the above example.
To reveal the true identity of sorted rare cells it is best to do so at the DNA level. In the case of high-throughput
fetal cell diagnostics, one can sort the cells of interest and then DNA type the cells on the basis of maternal and
paternal HLA-DQ alpha haplotypes (Figure 6). Using PCR primers as shown in Figure 6B and allele-specific
oligonucleotide (ASO) analysis (Figure 6A), we typed 10 sorted putative fetal cells. By comparing the maternal and
paternal DNA types as shown in Figure 6C we were able to show that while most of the putative fetal cells were
really maternal cells, at least one of the cells had to be fetal since it had the DNA type of the father. The identity of
the fetal cells obtained by high-throughput sorting was confirmed by DNA typing the baby after it was born.
Figure 6: (A) concept of allele specific oligo-
nucleotide (ASO) dot spot hybridization of DNA
sequences PCR amplified from rare sorted fetal cells,
(B) PCR primer sequences used to amplify HLA
DQa DNA sequences in the sorted cells, (C) ASO
dot spot hybridizations of PCR-amplified DNA
________________
sequences from cheek epithelial cells from a father,
______
mother and baby. Before the baby's birth fetal cells
were isolated from the mother's blood by high-speed
3-color fluorescence analysis. Note that the 10 sorted
putative fetal cells contain both paternal and
___________________________
maternal HLA-DQa alleles indicating that the sorted
cells contain a mixture of fetal and maternal cells,
demonstrating the need for single-cell, multi-tube
PCR analysis.
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PCR primers (Roche Molecular Systems) used
against maternal HLA-DQcc alleles to confirm
presence of fetal cells in maternal blood.
PROBE LENGTh SEQUENCE, 5' TO 3'
C 35-MER TTCTACGTGGACCTGGAGAGGAAG
GAGACTGCCTG
1 20-MER TGAGTTCAGCAAATTTGGAG
1.1 19-MER CGTAGAACTCCTCATCTCC
all but 1.3 18-MER GTCTCCTTCCTCTCCAGG
1.2, 1.3,4 19-MER GATGAGCAGTTCTACGTGG
1.3 18-MER CCTGGAGAAGAAGGAGAC
2 21-MER TTCCACAGACTIAGATTTGAC
3 19-MER TTCCGCAGATTTAGAAGAT
4 19-MER TGTTTGCCTGTTCTCAGAC
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4.5 High-speed library screening for recombinant vaccine production (RVP) against unknown pathogens
As the last example we describe briefly our newest HTS application —the screening of bacterial-pathogen
complexes for production of recombinant vaccines against unknown pathogens. Our collaborators, Drs. George
Georgiou and Brent Iverson have developed an expression library whereby all of the human immunoglobulin gene
recognition epitopes are expressed in a bacterial library (Georgiou et al., 1997). By then painting unknown
pathogens with a fluorescent dye, fluorescent bacterial-pathogen complexes can then be processed by HTS and
cloned to single-cell level as shown in Figure 7:
Bacterial clones biding the unknown pathogen can then be rapidly grown for use in production of a recombinant
vaccine. In order to be practical the total cell throughput must be at least 100,000 cells/sec, and rates of 300,000
cells/sec would be even more reasonable. This requires a very HTS instrument, beyond the realm of commercial
instruments. We are now making modifications to our high-speed cell sorter that should permit analysis rates of
greater than 300,000 cells/sec and practical sorting rates in excess of 100,000 cells/sec with single-cell cloning
capability.
4.6 The importance of HTS for gene expression microarray analyses
In the earlier examples of HTS we showed single cell, molecular characterization ofthe sorted cells. At present
this is not possible to do with gene expression microarrays. In fact, due to the low sensitivity ofthe current
generation of microarrays and their detection schemes, several hundred thousand cells are required for each
microarray. This represents a significant barrier to the pursuit of many biological and clinical problems where this
number of cells of a given cell subpopulation are simply not available. Nonetheless it is important to deliver purified
cell subpopulations to the microarray as shown in Figure X. Mixtures of cells on microarrays produce, as expected,
the superposition of gene expression profiles of all the cell subpopulations present according to their relative
amounts. Some times one can be lucky in that some genes are expressed only in certain cell types. In that case one
can typically see these genes from a 10 percent cell subpopulation. But when different cell subpopulations
Schematic of Bacterial Clone-Fluorescent Unknown Pathogen
Complexes & Potential Flow Cytometric Data
• •
Bacteñal clone
'1" containing rGFP
.
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Q
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Figure 7: Concept ofbacterial expression library containing all human immunoglobulin
recognition sequences. If one of the members of this library recognizes a pathogen, it will bind
that pathogen in a complex. If the complex is sorted by HTS methods, the bacterial clones can
be grown to produce a recombinant vaccine against that pathogen.
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differentially express genes, e.g. moderate versus strong expression of a particular gene, the gene expression profile
of a given cell subpopulation becomes quickly lost even at frequencies of 30 percent or more as shown in Figure Y.
In this case we created defined cell mixtures ofhuman CEM T-cells and A2780 human ovarian carcinoma cells to
simulate the effect ofa tissue containing a mixture ofboth cell types. Some genes are expressed in one cell type but
not the other as shown by the circled genes. Other genes are expressed in both cell types but at different levels.
C 0
i;:i
$ '
o 0
, * 1_ *'* . , , 3 *
Pure CEM cells 1:10 cell mixture
. I I CEM:AZ7SOcells
'0 0
•*0 0
1 ' 4 4 * •. 1**
Pure A2780 cells CEM cells separated
from 1:10 cell mixture
Figure 8: Sometimes genes ofdifferent cell subpopulations or types differentially express genes as shown by
the boxed examples. Other times, one cell type or subpopulation expresses a particular gene while another
does not as shown in the circled examples. The gene expression profile of a cell mixture is the superposition
ofthe gene expression profiles ofall the cell subpopulations or type present as shown in panel B. But when
the cells are separated by HTS, the gene expression profile ofthe separated cell subpopulation looks very
different from the mixture and very similar to what it would look like if it were a pure cell subpopulation.
People in the laser capture microdissection field have been struggling with this problem for some time. They have
developed a number ofpre-amplification methods to expand the number oftarget molecules before microarray
analysis (Eberwine, 1996; Gonzalez et al., 1999). But it is very difficult to amplify the mRNA from small numbers
of cells without distorting the relative gene expression profile as compared to what it would be without the pre-
amplification. HTS can present as many purified cell types to a microarray as possible, but there may be
fundamental limits posed by the biology. The solution to this fundamental problem is a mixture of improvements in
microarray sensitivity so that fewer cells are needed, and pre-amplification methods that expand all genes equally in
a linear and reproducible fashion. HTS is also important since RNA degradation can be a significant problem. Since
RNA rapidly degrades, and specific mRNAs turn over in minutes or hours, cell separation process must be very
rapid. Cell fixation may be one possible solution to the rapid degradation of mRNA problem (Goldsworthy et al.,
1999) They found that rapid fixation of frozen tissue in 70% ethanol produced the best results, but acceptable results
were obtained with a variety of other fixatives.
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5. CONCLUSIONS
High throughput technologies, including high-speed flow cytometry and cell sorting, are important to clinical
diagnostics and therapeutics. Post-separation molecular characterization technologies such as single-cell PCR and
single cell sequencing and gene expression microarray analyses depend on the delivery of purified cells or cell
subpopulations. Otherwise these molecular characterization technologies superimpose the DNA sequence or gene
expression profile patterns ofthe different cell types present. In particular, gene expression profiles from microarray
analyses performed on mixtures of cell types, cell cycle and cell differentiation stages, activated and non-activated
cells are at best compromised in value, and at worst of little value.
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